Annual CAPEX:
$974.00M+$197.00M(+25.35%)Summary
- As of today, ABBV annual capital expenditures is $974.00 million, with the most recent change of +$197.00 million (+25.35%) on December 31, 2024.
- During the last 3 years, ABBV annual CAPEX has risen by +$187.00 million (+23.76%).
- ABBV annual CAPEX is now at all-time high.
Performance
ABBV CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$381.00M+$112.00M(+41.64%)Summary
- As of today, ABBV quarterly capital expenditures is $381.00 million, with the most recent change of +$112.00 million (+41.64%) on September 30, 2025.
- Over the past year, ABBV quarterly CAPEX has increased by +$132.00 million (+53.01%).
- ABBV quarterly CAPEX is now -74.24% below its all-time high of $1.48 billion, reached on December 31, 2020.
Performance
ABBV Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$1.18B+$132.00M(+12.64%)Summary
- As of today, ABBV TTM capital expenditures is $1.18 billion, with the most recent change of +$132.00 million (+12.64%) on September 30, 2025.
- Over the past year, ABBV TTM CAPEX has increased by +$288.00 million (+32.43%).
- ABBV TTM CAPEX is now -43.43% below its all-time high of $2.08 billion, reached on June 30, 2021.
Performance
ABBV TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ABBV CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +25.4% | +53.0% | +32.4% |
| 3Y3 Years | +23.8% | +115.3% | +75.8% |
| 5Y5 Years | +76.5% | +75.6% | +72.4% |
ABBV CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +40.1% | at high | +117.7% | at high | +75.8% |
| 5Y | 5-Year | at high | +76.5% | -74.2% | +166.4% | -43.4% | +75.8% |
| All-Time | All-Time | at high | +211.6% | -74.2% | +2057.3% | -43.4% | +1114.3% |
ABBV CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $381.00M(+41.6%) | $1.18B(+12.6%) |
| Jun 2025 | - | $269.00M(+14.5%) | $1.04B(+2.8%) |
| Mar 2025 | - | $235.00M(-19.2%) | $1.02B(+4.3%) |
| Dec 2024 | $974.00M(+25.4%) | $291.00M(+16.9%) | $974.00M(+9.7%) |
| Sep 2024 | - | $249.00M(+3.3%) | $888.00M(+3.5%) |
| Jun 2024 | - | $241.00M(+24.9%) | $858.00M(+7.9%) |
| Mar 2024 | - | $193.00M(-5.9%) | $795.00M(+2.3%) |
| Dec 2023 | $777.00M(+11.8%) | $205.00M(-6.4%) | $777.00M(-1.0%) |
| Sep 2023 | - | $219.00M(+23.0%) | $785.00M(+5.7%) |
| Jun 2023 | - | $178.00M(+1.7%) | $743.00M(+4.9%) |
| Mar 2023 | - | $175.00M(-17.8%) | $708.00M(+1.9%) |
| Dec 2022 | $695.00M(-11.7%) | $213.00M(+20.3%) | $695.00M(+3.9%) |
| Sep 2022 | - | $177.00M(+23.8%) | $669.00M(-5.6%) |
| Jun 2022 | - | $143.00M(-11.7%) | $709.00M(-6.8%) |
| Mar 2022 | - | $162.00M(-13.4%) | $761.00M(-3.3%) |
| Dec 2021 | $787.00M(-1.4%) | $187.00M(-13.8%) | $787.00M(-62.1%) |
| Sep 2021 | - | $217.00M(+11.3%) | $2.08B(0.0%) |
| Jun 2021 | - | $195.00M(+3.7%) | $2.08B(+0.9%) |
| Mar 2021 | - | $188.00M(-87.3%) | $2.06B(+3.2%) |
| Dec 2020 | $798.00M(+44.6%) | $1.48B(+581.6%) | $2.00B(+193.0%) |
| Sep 2020 | - | $217.00M(+22.6%) | $682.00M(+10.2%) |
| Jun 2020 | - | $177.00M(+41.6%) | $619.00M(+8.6%) |
| Mar 2020 | - | $125.00M(-23.3%) | $570.00M(+3.3%) |
| Dec 2019 | $552.00M(-13.5%) | $163.00M(+5.8%) | $552.00M(+7.8%) |
| Sep 2019 | - | $154.00M(+20.3%) | $512.00M(-20.0%) |
| Jun 2019 | - | $128.00M(+19.6%) | $640.00M(+2.2%) |
| Mar 2019 | - | $107.00M(-13.0%) | $626.00M(-1.9%) |
| Dec 2018 | $638.00M | $123.00M(-56.4%) | $638.00M(-8.5%) |
| Sep 2018 | - | $282.00M(+147.4%) | $697.00M(+28.8%) |
| Jun 2018 | - | $114.00M(-4.2%) | $541.00M(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $119.00M(-34.6%) | $553.00M(+4.5%) |
| Dec 2017 | $529.00M(+10.4%) | $182.00M(+44.4%) | $529.00M(+14.8%) |
| Sep 2017 | - | $126.00M(0.0%) | $461.00M(+2.9%) |
| Jun 2017 | - | $126.00M(+32.6%) | $448.00M(-1.1%) |
| Mar 2017 | - | $95.00M(-16.7%) | $453.00M(-5.4%) |
| Dec 2016 | $479.00M(-10.0%) | $114.00M(+0.9%) | $479.00M(-6.1%) |
| Sep 2016 | - | $113.00M(-13.7%) | $510.00M(-2.7%) |
| Jun 2016 | - | $131.00M(+8.3%) | $524.00M(+3.1%) |
| Mar 2016 | - | $121.00M(-16.6%) | $508.00M(-4.5%) |
| Dec 2015 | $532.00M(-13.1%) | $145.00M(+14.2%) | $532.00M(-1.5%) |
| Sep 2015 | - | $127.00M(+10.4%) | $540.00M(-8.9%) |
| Jun 2015 | - | $115.00M(-20.7%) | $593.00M(-4.4%) |
| Mar 2015 | - | $145.00M(-5.2%) | $620.00M(+1.3%) |
| Dec 2014 | $612.00M(+24.6%) | $153.00M(-15.0%) | $612.00M(+0.3%) |
| Sep 2014 | - | $180.00M(+26.8%) | $610.00M(+8.3%) |
| Jun 2014 | - | $142.00M(+3.6%) | $563.00M(+4.3%) |
| Mar 2014 | - | $137.00M(-9.3%) | $540.00M(+10.0%) |
| Dec 2013 | $491.00M(+47.4%) | $151.00M(+13.5%) | $491.00M(+13.0%) |
| Sep 2013 | - | $133.00M(+11.8%) | $434.54M(+36.1%) |
| Jun 2013 | - | $119.00M(+35.2%) | $319.20M(+8.5%) |
| Mar 2013 | - | $88.00M(-6.9%) | $294.12M(-20.1%) |
| Dec 2012 | $333.00M(-6.5%) | $94.54M(+435.3%) | $368.32M(-2.6%) |
| Sep 2012 | - | $17.66M(-81.2%) | $378.19M(-10.7%) |
| Jun 2012 | - | $93.92M(-42.1%) | $423.70M(+0.7%) |
| Mar 2012 | - | $162.20M(+55.4%) | $420.87M(+18.4%) |
| Dec 2011 | $356.00M(-20.5%) | $104.41M(+65.3%) | $355.51M(+41.6%) |
| Sep 2011 | - | $63.17M(-30.7%) | $251.10M(+33.6%) |
| Jun 2011 | - | $91.09M(-5.9%) | $187.94M(+94.1%) |
| Mar 2011 | - | $96.85M | $96.85M |
| Dec 2010 | $448.00M(+43.3%) | - | - |
| Dec 2009 | $312.56M | - | - |
FAQ
- What is AbbVie Inc. annual capital expenditures?
- What is the all-time high annual CAPEX for AbbVie Inc.?
- What is AbbVie Inc. annual CAPEX year-on-year change?
- What is AbbVie Inc. quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for AbbVie Inc.?
- What is AbbVie Inc. quarterly CAPEX year-on-year change?
- What is AbbVie Inc. TTM capital expenditures?
- What is the all-time high TTM CAPEX for AbbVie Inc.?
- What is AbbVie Inc. TTM CAPEX year-on-year change?
What is AbbVie Inc. annual capital expenditures?
The current annual CAPEX of ABBV is $974.00M
What is the all-time high annual CAPEX for AbbVie Inc.?
AbbVie Inc. all-time high annual capital expenditures is $974.00M
What is AbbVie Inc. annual CAPEX year-on-year change?
Over the past year, ABBV annual capital expenditures has changed by +$197.00M (+25.35%)
What is AbbVie Inc. quarterly capital expenditures?
The current quarterly CAPEX of ABBV is $381.00M
What is the all-time high quarterly CAPEX for AbbVie Inc.?
AbbVie Inc. all-time high quarterly capital expenditures is $1.48B
What is AbbVie Inc. quarterly CAPEX year-on-year change?
Over the past year, ABBV quarterly capital expenditures has changed by +$132.00M (+53.01%)
What is AbbVie Inc. TTM capital expenditures?
The current TTM CAPEX of ABBV is $1.18B
What is the all-time high TTM CAPEX for AbbVie Inc.?
AbbVie Inc. all-time high TTM capital expenditures is $2.08B
What is AbbVie Inc. TTM CAPEX year-on-year change?
Over the past year, ABBV TTM capital expenditures has changed by +$288.00M (+32.43%)